Nektar Therapeutics Inc. (NKTR) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Nektar Therapeutics (NKTR) relies on external contract manufacturing organizations for the production of immunological agents. The shift in the EV/EBITDA multiple reflects the business valuation dynamics, where 0.00 indicates the value of this parameter. Currently, the company's development is tied to oncology startups following the failure of its primary research, while geopolitical tensions and sanctions are hindering international clinical trials.
Nektar Therapeutics Inc. - analytical breakdowns and key metrics (NKTR)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
NKTR - Net Profit|Future Profit Nektar Therapeutics|NKTR - Market Price to Net Income Ratio|Forward P/E Multiple nektar.com|NKTR - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nektar Therapeutics Inc|NKTR - Income before deduction of interest, taxes and amortization|Net earnings per share for the last 12 months Nektar Therapeutics|NKTR - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months nektar.com|NKTR - Net earnings per one share growth for the current year|Earnings growth forecast for next year Nektar Therapeutics
- sales and revenue data:
Initial company analysis:NKTR (Nektar Therapeutics Inc.)
This indicator determines the fundamental business value by comparing total capital and net debt against operating profit before depreciation and amortization. By analyzing the EV/EBITDA chart, an investor assesses the asset efficiency of Nektar Therapeutics (NKTR), where the absence of capacity wear and stable laboratory utilization provide a sustainable base for servicing obligations and company capitalization.
Competitor analysis for Nektar Therapeutics
EV/EBITDA Multiple ARGX (argenx.com)|Total Company Value to Operating Income Before Depreciation Ratio biontech.de (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ADMA Biologics Inc (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist Corp (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant, Inc.|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple grifols.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies Corp (ADPT)|Celldex Therapeutics, Inc. - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (auriniapharma.com)|BioCryst Pharmaceuticals Inc (BCRX) - Company Value to EBITDA|VERA: Enterprise Value to EBITDA Ratio|DNTH (Dianthus Therapeutics) - Enterprise Value to Operating Income Before Depreciation|PHVS: EV/EBITDA Multiple|ABCL (AbCellera Biologics Inc.) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio TRML|Company Value to EBITDA Intrexon PGEN|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pharming Group N.V. (PHAR)|UPB (Upstream Bio Inc) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zenas Bio ZBIO|IMNM: Enterprise Value to Operating Income Before Depreciation|GOSS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio KalVista Pharmaceuticals KALV|Septerna (SEPN) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|pieris.com - Business Value to Operating Income Before Depreciation|SVRA (Savara Inc) - EV/EBITDA Multiple|RIGL: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ANAB|ATXS (Astria Pharma) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization enGene Holdings Inc. ENGN|EV/EBITDA Multiple RAPT Therapeutics Inc. RAPT|Aerovate Therapeutics - EV/EBITDA Multiple|Company Value to EBITDA Aclaris Therapeutics Inc.|Kyverna (KYTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Tiziana Life Sciences (TLSA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cabaletta Bio Inc.|Ventyx Biosciences (VTYX) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple THTX|EV/EBITDA Multiple Avalo Therapeutics Inc. (AVTX)|EV/EBITDA Multiple ELDN (eledon.com)|AGEN - Enterprise Value to EBITDA Ratio|CLYM: Enterprise Value to EBITDA Ratio|ZURA (Zura Bio Limited) - Enterprise Value to Operating Income Before Depreciation|ATYR: EV/EBITDA Multiple|Adagene (ADAG) - EV/EBITDA Multiple|IMA (ikenaoncology.com) - EV/EBITDA Multiple|shattucklabs.com (STTK) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Equillium Inc (EQ)|Connect Pharma - Enterprise Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Immunic, Inc. IMUX|ATRA - Enterprise Value to EBITDA Ratio|IFRX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|XFOR: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ACET: EV/EBITDA Multiple|Celularity Corp (CELU) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INmune Bio|Barinthus Biotherapeutics plc (BRNS) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple KZR|SABS: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AKTX (Akari Therapeutics, Plc)|ENLV (Enlivex Therapeutics, Ltd.) - Company Value to Operating Income Before Depreciation Ratio|QTTB: Enterprise Value to EBITDA Ratio|GOVX - EV/EBITDA Multiple|Edesa Biotech Corp (EDSA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|IBIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization carismatx.com|XTLB: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bolt Biotherapeutics Inc. (BOLT)|HCWB (HCW Biologics) - Business Value to Operating Income Before Depreciation|Aptevo Therapeutics - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple AIM ImmunoTech Inc. AIM|Aditxt Inc. - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation GRI (GRI Bio, Inc.)|XORTX Therapeutics Inc (XRTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio ReShape Lifesciences|Enterprise Value to EBITDA Ratio REVB|Indaptus Corp (INDP) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization scinai.com (SCNI)|Enterprise Value to EBITDA Ratio CalciMedica CALI|EV/EBITDA Multiple AFMD (affimed.com)|Allakos Inc. (ALLK) - Company Value to EBITDA|HOOKIPA - EV/EBITDA Multiple|IGMS (igmbio.com) - Enterprise Value to Operating Income Before Depreciation|ITOS (iTeos) - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation OCEA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC BioPharm|Third Harmonic Bio Inc. (THRD) - Total Company Value to Operating Income Before Depreciation Ratio
